More high-quality years of life are lost due to stroke than to any other disease. The disability caused by the disease can be significantly reduced by efficient treatment of those affected.
A stroke occurs when a blood clot blocks a vessel or artery, or when a blood vessel breaks, interrupting blood flow to an area of the brain. When a stroke occurs, it kills brain cells in the immediate area. This can happen anytime from a few minutes after the stroke starts to a few hours later.
Find out more on Boehringer Ingelheim's corporate website on prevention and treatment of stroke:
Indicated for thrombolytic treatment in acute ischaemic stroke.
Actilyse® is also registered for the indication acute myocardial infarction which can be found under "Acute Coronary Disease".
Actilyse® is also indicated in acute massive pulmonary embolism.
Actilyse® Cathflo is indicated for catheter clearance due to thrombotic occlusion.
Aggrenox®, Asasantin®Retard (dipyridamole/ASA)
Indicated to reduce the risk of stroke in patients who have had transient ischaemia of the brain or completed ischaemic stroke due to thrombosis.
We recognise that the Internet serves a global community. The pharmaceutical industry, however, is subject to country specific regulatory considerations, which affect the information we can provide on our products. In addition the registration status of pharmaceutical products may not be the same in different regions of the world and the approved product labels may also differ according to country specific requirements.
Therefore please check the registration details of this/these product(s) locally in order to get up-to-date information.